SF3B1 and cancer: Additionally, unlike both SUGP1 and DHX15 (Liu et al. 2020; Alsafadi et al. 2021; Zhang et al. 2022a), DDX46 is not known to harbor any cancer-associated mutations that recapitulate mutant SF3B1 missplicing.